Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
Is Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged AI analysis
What does Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged do?
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified. It is in Medical - Pharmaceuticals.
How has Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged stock done over the past year?
Down 14.2% over the past twelve months, to $23.40. It traded between $19.76 and $33.89 and is 31.0% below its high.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.